A detailed history of Massachusetts Wealth Management transactions in Eli Lilly & CO stock. As of the latest transaction made, Massachusetts Wealth Management holds 2,560 shares of LLY stock, worth $2.02 Million. This represents 1.43% of its overall portfolio holdings.

Number of Shares
2,560
Previous 2,215 15.58%
Holding current value
$2.02 Million
Previous $2.01 Billion 13.09%
% of portfolio
1.43%
Previous 1.35%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$772.14 - $960.02 $266,388 - $331,206
345 Added 15.58%
2,560 $2.27 Billion
Q2 2024

Jul 31, 2024

BUY
$724.87 - $909.04 $416,800 - $522,698
575 Added 35.06%
2,215 $2.01 Billion
Q1 2024

Apr 19, 2024

BUY
$592.2 - $792.28 $162,855 - $217,877
275 Added 20.15%
1,640 $1.28 Billion
Q4 2023

Jan 24, 2024

BUY
$525.19 - $619.13 $412,274 - $486,017
785 Added 135.34%
1,365 $796 Million
Q2 2023

Aug 03, 2023

BUY
$350.74 - $468.98 $203,429 - $272,008
580 New
580 $272 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $750B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Massachusetts Wealth Management Portfolio

Follow Massachusetts Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Massachusetts Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Massachusetts Wealth Management with notifications on news.